Ticker Scorecard - PRTA Basics Company: Prothena Corporation plc Ordinary Shares IPO Date: December 21, 2012 Sector: Healthcare Industry: Biotech Market Cap: $836.69M Activated in VL: True Average Daily Range Avg Daily Range: $0.91 | 2.90% Avg Daily Range (30 D): $0.42 | 2.98% Avg Daily Range (90 D): $0.53 | 3.50% Institutional Daily Volume Avg Daily Volume: .34M Avg Daily Volume (30 D): .28M Avg Daily Volume (90 D): .39M Trade Size Avg Trade Size (Sh.): 77 Avg Trade Size (Sh.) (30 D): 53 Avg Trade Size (Sh.) (90 D): 56 Institutional Trades Total Inst.Trades: 3,282 Avg Inst. Trade: $1.9M Avg Inst. Trade (30 D): $.85M Avg Inst. Trade (90 D): $1.08M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.27M Avg Closing Trade (30 D): $.81M Avg Closing Trade (90 D): $1.09M Avg Closing Volume: 64.66K     News Feb 17, 2025 @ 11:10 PM Kuehn Law Encourages Investors of Prothena Corpora... Source: N/A Feb 13, 2025 @ 6:00 PM Alpha-Synuclein Inhibitors Clinical Trial Pipeline... Source: Delveinsight Dec 19, 2024 @ 4:31 PM Roche-Prothena Partnered Mid-Stage Parkinson's Tri... Source: Benzinga Oct 14, 2024 @ 5:00 PM Tau Inhibitors Clinical Trial Pipeline Analysis De... Source: Delveinsight Jun 24, 2024 @ 12:48 PM Prothena (PRTA) Moves 9.3% Higher: Will This Stren... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-2.46 $-1.1 $1.24 Diluted EPS $-2.46 $-1.1 $1.22 Revenue $ 133.35M $ .97M $ 132.01M Gross Profit $ $ $ Net Income / Loss $ -131.83M $ -59M $ 66.89M Operating Income / Loss $ -168.18M $ -66.51M $ 58.38M Cost of Revenue $ $ $ Net Cash Flow $ -152.99M $ -44.86M $ 16.26M PE Ratio